Paul R. Reid

Discovery and development of a second highly selective M1 Positive Allosteric Modulator (PAM)

C. Lindsley, C. Weaver, E. Dawson, 2010 .

Decoupling Activation of Heme Biosynthesis from Anaerobic Toxicity in a Molecule Active in Staphylococcus aureus.

E. Skaar, Laura A. Mike, G. Sulikowski, 2016, ACS chemical biology.

Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN probe.

D. Sheffler, C. Lindsley, Hyekyung P. Cho, 2011, Bioorganic & medicinal chemistry letters.

Discovery of tertiary sulfonamides as potent liver X receptor antagonists.

Paul R Reid, Timothy M Willson, William J Zuercher, 2010, Journal of medicinal chemistry.

An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model.

R. A. Reid, D. J. Price, D. Drewry, 2018, Bioorganic & medicinal chemistry letters.

Allosteric Antagonism of Insect Odorant Receptor Ion Channels

Robert W. Taylor, A. Waterson, L. Zwiebel, 2012, PloS one.

Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.

Anna L. Blobaum, D. Sheffler, C. Lindsley, 2012, ACS chemical neuroscience.

Activation of heme biosynthesis by a small molecule that is toxic to fermenting Staphylococcus aureus

Eric P. Skaar, R. Caprioli, A. Richardson, 2013, Proceedings of the National Academy of Sciences.